MetaCap

Rallybio (RLYB) News

NASDAQ: RLYBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

15.47-0.05 (-0.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

RLYB news summary

We found 2 recent headlines mentioning Rallybio (RLYB): 0 in the past week and 2 in the past 30 days, most often from Business Wire, Nasdaq. For price context, RLYB is down 0.32% at $15.47. The most recent story, "Correction to Press Release Announcing Reverse Stock Split of Rallybio Common Stock in Connection with the Proposed Merger with Avenzo", was published by Business Wire on Nov 11, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Rallybio headlines

Compare RLYB